With over 20 years of experience, we offer custom made development solutions in every stage of development from proof of concept to late stage programmes.
Founded in 1997, Ergomed plc is dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs. Operating with a global footprint in over 55 countries, Ergomed enables our clients to access solutions even for their toughest clinical development and trial management challenges from early phase to complex late stage programmes. Ergomed has provided and managed clinical development, trial management and pharmacovigilance services for over 100 clients: these ranging from top 10 pharmaceutical and generics organizations to small and mid-sized drug development companies.
As a global CRO, Ergomed has a worldwide network designed to specifically match the requirements of today’s complex development programs. Our global reach allows us to support the development and writing of protocols, fulfill the regulatory requirements, and then to identify, enroll and process patients who are the best fit for the study. Our experienced team is here to support your program from start to finish, ensuring that your study remains on time and on budget.